N-(2-(Pyridin-2-yl)benzyl)propan-2-amine, 95%, 100mg

2-Bromo-6-chlorobenzo[d]thiazole, 95.0%, 10g

4-Amino-1-methylpyridin-2(1H)-one, 95.0%, 5g

methyl 2-(2-acetamido-4-bromophenyl)acetate, 95.0%, 250mg

Natriumdihydrogenphosphat-Monohydrat, min. 98 %, p.a., ACS, 25 kg, kunststoffverpackung.

Methyl 5-formyl-1-phenyl-1H-pyrazole-4-carboxylate, 95.0%, 5g

Probenröhrchen, PE, Ø 9 mm, 1 ml, mit Eindrückdeckel, 100 Stück

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(benzyloxy)-5-oxopentanoic acid, 98%, 25g

Ethyl 1-Methylimidazole-2-carboxylate>98.0%(GC)(T)1g

Palladium(II)-oxid, Hydrat 10 g

(R)-TERT-BUTYL 2-(2-(METHYLAMINO)THIAZOL-4-YL)PYRROLIDINE-1-CARBOXYLATE, 90.0%, 1g

(3R,5R)-tert-Butyl 3,5-dimethylpiperazine-1-carboxylate, 95.0%, 500mg

2-Bromo-3,4-dichloro-6-fluorotoluene, 5g